Bank of America’s Petros Pharmaceuticals PTPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$5 | – | 8615 |
|
|
2025
Q1 | $5 | Hold |
3
| – | – | ﹤0.01% | 8240 |
|
|
2024
Q4 | $29 | Hold |
3
| – | – | ﹤0.01% | 7962 |
|
|
2024
Q3 | $26 | Buy |
3
+1
| +50% | +$9 | ﹤0.01% | 7929 |
|
|
2024
Q2 | $25 | Buy |
+2
| New | +$32 | ﹤0.01% | 7963 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7655 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7945 |
|
|
2023
Q3 | – | Sell |
-1
| Closed | -$68 | – | 7717 |
|
|
2023
Q2 | $28 | Hold |
1
| – | – | ﹤0.01% | 7499 |
|
|
2023
Q1 | $19 | Buy |
+1
| New | +$57 | ﹤0.01% | 7576 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8145 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8324 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8013 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7704 |
|
Bank of America's PTPI Position: Q2 2025 in Review
Bank of America sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 3 shares — an estimated $5 sold.
Bank of America first reported a position in PTPI in Q1 2023 and held it in 6 quarters. The position peaked at $29 in Q4 2024. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.
- Bank of America reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Bank of America sold 3 Petros Pharmaceuticals shares in Q2 2025, an estimated $5.
- Bank of America first reported a position in Petros Pharmaceuticals in Q1 2023 and held it in 6 quarters.
- Bank of America's Petros Pharmaceuticals position peaked at $29 in Q4 2024.
- 0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.
Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.